Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-03

FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for KLONOPIN (clonazepam) filed by H2-Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLONOPIN (clonazepam)

Snippet

SUPPL AP for KLONOPIN (CLONAZEPAM)